X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (132) 132
science & technology (132) 132
humans (92) 92
cardiovascular system & cardiology (81) 81
hematology (78) 78
female (69) 69
peripheral vascular disease (62) 62
male (61) 61
anticoagulants (60) 60
middle aged (47) 47
aged (46) 46
rivaroxaban (46) 46
venous thromboembolism (39) 39
treatment outcome (37) 37
thromboembolism (36) 36
anticoagulants - therapeutic use (30) 30
risk factors (30) 30
cardiac & cardiovascular systems (29) 29
bleeding (27) 27
aged, 80 and over (26) 26
hemorrhage - chemically induced (26) 26
anticoagulants - adverse effects (25) 25
prospective studies (23) 23
adult (22) 22
thrombosis (22) 22
care and treatment (21) 21
registries (21) 21
general & internal medicine (20) 20
abridged index medicus (19) 19
atrial fibrillation (19) 19
pulmonary embolism (19) 19
anticoagulants - administration & dosage (18) 18
medicine, general & internal (18) 18
venous thromboembolism - drug therapy (18) 18
administration, oral (17) 17
drug therapy (17) 17
recurrence (17) 17
analysis (16) 16
anticoagulation (15) 15
hemorrhage (15) 15
mortality (15) 15
rivaroxaban - therapeutic use (15) 15
cancer (14) 14
patients (14) 14
risk assessment (14) 14
vitamin k - antagonists & inhibitors (14) 14
factor xa inhibitors - therapeutic use (13) 13
hematology, oncology and palliative medicine (13) 13
medicine & public health (13) 13
prevention (13) 13
retrospective studies (13) 13
atrial fibrillation - drug therapy (12) 12
dosage and administration (12) 12
rivaroxaban - administration & dosage (12) 12
warfarin (12) 12
dabigatran (11) 11
factor xa inhibitors - administration & dosage (11) 11
health risk assessment (11) 11
rivaroxaban - adverse effects (11) 11
time factors (11) 11
venous thrombosis (11) 11
cardiology (10) 10
factor xa inhibitors - adverse effects (10) 10
medical research (10) 10
stroke - prevention & control (10) 10
cardiovascular diseases (9) 9
cohort studies (9) 9
diagnosis (9) 9
embolisms (9) 9
follow-up studies (9) 9
heparin (9) 9
medicine, experimental (9) 9
research (9) 9
stroke, systemic or venous thromboembolism (9) 9
venous thrombosis - drug therapy (9) 9
apixaban (8) 8
deep vein thrombosis (8) 8
life sciences (8) 8
neoplasms - complications (8) 8
pregnancy (8) 8
risk (8) 8
usage (8) 8
clinical trials (7) 7
double-blind method (7) 7
drug administration schedule (7) 7
pulmonary embolism - drug therapy (7) 7
stroke (7) 7
studies (7) 7
venous thromboembolism - prevention & control (7) 7
vitamin k antagonist (7) 7
acute disease (6) 6
atrial fibrillation - complications (6) 6
deep-vein thrombosis (6) 6
direct oral anticoagulants (6) 6
edoxaban (6) 6
germany (6) 6
hospitalization (6) 6
management (6) 6
pharmacology & pharmacy (6) 6
polysaccharides - therapeutic use (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 03/2017, Volume 69, Issue 12, pp. 1536 - 1544
Abstract Background The long-term effect of thrombolytic treatment of pulmonary embolism (PE) is unknown. Objectives This study investigated the long-term... 
Cardiovascular | Internal Medicine | chronic thromboembolic pulmonary hypertension | thrombolysis | long-term survival | pulmonary embolism | prognosis | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Pulmonary Embolism - prevention & control | Echocardiography | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Tissue Plasminogen Activator - therapeutic use | Pulmonary Embolism - mortality | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy | Aged, 80 and over | Female | Aged | Tenecteplase | Pulmonary Embolism - diagnostic imaging | Pulmonary embolism | Stroke (Disease) | Medicine, Experimental | Medical research | Cardiology | Cardiovascular agents | Heart | Therapy | Chest | Incidence | Design | Computed tomography | Motivation | Tomography | Diagnosis | Thromboembolism | Anticoagulants | Pulmonary arteries | Mortality | Statistical tests | Patients | Fibrinolysis | Survival | Computation | Diagnostic software | Death | Health risk assessment | Risk management | Angiography | Arches | Embolisms | Clinical trials | Population studies | Hemorrhage | Bleeding | Guidelines | Reperfusion | Risk assessment | Calcium-binding protein | Trends | Heart diseases | Injuries | Hypertension | Collapse | Stroke | Statistical analysis | Receiving | Complications | Risk reduction | Statistics | Pulmonary hypertension | Embolism | Computer programs | Contact | Thromboplastin | Medical prognosis | Fatalities | Ventricle | Heparin | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2016, Volume 375, Issue 12, pp. 1131 - 1141
Journal Article
The New England journal of medicine, ISSN 1533-4406, 03/2017, Volume 376, Issue 13, pp. 1211 - 1222
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2019, Volume 380, Issue 14, pp. 1326 - 1335
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2014, Volume 370, Issue 15, pp. 1402 - 1411
Journal Article
Journal Article
by Farge, Dominique and Frere, Corinne and Connors, Jean M and Ay, Cihan and Khorana, Alok A and Munoz, Andres and Brenner, Benjamin and Kakkar, Ajay and Rafii, Hanadi and Solymoss, Susan and Brilhante, Dialina and Monreal, Manuel and Bounameaux, Henri and Pabinger, Ingrid and Douketis, James and Ageno, Walter and Ajauro, Fernando and Al-Aboudi, Kamal R and Alcindor, Thierry and Andre, Thierry and Angchaisuksiri, Pantep and Antic, Darko and Arcelus, Juan I and Assenat, Eric and Bauer, Kenneth A and Bazarbachii, Ali and Benzidia, Ilham and Beyer-Westendorf, Jan and Bitsadze, Viktoria and Blickstein, Dorit and Blostein, Mark and Bogalho, Isabel and Bournet, Barbara and Casais, Patricia and Carpentier, Antoine F and Cesarman-Maus, Gabriela and Chakbrabartty, Joydeep and Clemente, Hugo and Connault, Jérôme and Doucet, Ludovic and Durant, Cécile and Emmerich, Joseph and Falanga, Anna and Feistritzer, Clemens and Font, Carme and Francis, Charles and Gallardo, Enrique and Gary, Thomas and Gris, Jean-Christophe and Guillermo, Cecilia and Hij, Adrian and Hull, Russel D and IKezoe, Takayuki and Jara-Palomares, Luis and Key, Nigel S and Khrizroeva, Jamilya and Koolian, Maral and Langer, Florian and Le Hello, Claire and Lecumberri, Ramón and Lee, Lai Heng and Liebman, Howard and Lopes Dos Santos, Luisa and Machado, Duarte Henrique and Madelaine, Isabelle and Makatsariya, Alexander and Mandala, Mario and Marayevas, Anthony and Marjanovic, Zora and Marosi, Christine and Martin, Ellis and Meillon, Luis and Messas, Emmanuel and Moreira, Antonio and Demir, Ahmet M and Ndour, Arlette and Nguessan, Michel and Otero-Candelera, Remedios and Pachon Olmos, Vanessa and Pais, Ana and Posch, Florian and Preusser, Matthias and Riess, Hanno and Righini, Marc and Rothschild, Cynthia and Roussin, Andre and Rueda-Camino, José Antonio and Ruiz-Artacho, Pedro and Saseedharan, Sanjith and Shamseddine, Ali and Soff, Gerald and Stricker, Hans and Tagalakis, Vicky and Taher, Ali and Toussaint, Toutou and Trujillo-Santos, Javier and Villiers, Stéphane and Wong, Raymond and Yamada, Norizaku and International Initiative on Thrombosis and Cancer (ITAC) advisory panel and Int Initiative Thrombosis Canc ITA
The lancet oncology, ISSN 1470-2045, 10/2019, Volume 20, Issue 10, pp. e566 - e581
SummaryVenous thromboembolism (VTE) is the second leading cause of death in patients with cancer. These patients are at a high risk of VTE recurrence and... 
Hematology, Oncology, and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article